DiaSorin S.p.A.

General ticker "DSRLF" information:

  • Sector: Health Care
  • Industry: Medical - Diagnostics & Research
  • Capitalization: $4.9B (TTM average)

DiaSorin S.p.A. does not follow the US Stock Market performance with the rate: -23.6%.

Estimated limits based on current volatility of 1.0%: low 79.27$, high 80.80$

Factors to consider:

  • Earnings expected soon, date: nan
  • Company pays dividends (annually): last record date 2026-05-19, amount 1.51$ (Y1.86%)
  • Earnings for 15 months up through Q1 (+1 year) are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [93.85$, 131.02$]
  • 2025-12-31 to 2026-12-31 estimated range: [95.63$, 133.74$]

Similar symbols

Short-term DSRLF quotes

Long-term DSRLF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €1,361.14MM €1,148.21MM €1,185.43MM
Operating Expenses €1,009.88MM €931.95MM €927.10MM
Operating Income €351.26MM €216.26MM €258.32MM
Non-Operating Income €-25.32MM €-15.04MM €-15.88MM
Interest Expense €34.97MM €29.34MM €28.61MM
R&D Expense €96.90MM €90.95MM €91.57MM
Income(Loss) €325.94MM €201.22MM €242.45MM
Taxes €85.83MM €42.71MM €55.39MM
Net Income(Loss)* €240.91MM €159.85MM €188.10MM
Stockholders Equity €1,518.99MM €1,538.61MM €1,800.92MM
Inventory €306.50MM €315.50MM €344.04MM
Assets €3,408.08MM €3,211.44MM €3,304.92MM
Operating Cash Flow €389.34MM €311.66MM €358.78MM
Capital expenditure €113.69MM €45.47MM €119.72MM
Investing Cash Flow €-231.95MM €-29.10MM €-49.81MM
Financing Cash Flow €-333.04MM €-235.96MM €-259.13MM
Earnings Per Share** €4.17 €2.87 €3.37

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.